Atea Pharmaceuticals, Inc. (AVIR) Net margin 2021–2022
Atea Pharmaceuticals, Inc. (AVIR) net profit margin by fiscal year — reported net income divided by reported revenue.
-33.0%FY2022 · since FY2021: 249.2% → -33.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -33.0% | -282.2 pp |
| FY2021 | 249.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More AVIR financial trends
AVIR RevenueAVIR Net incomeAVIR Gross profitAVIR Gross marginAVIR Operating incomeAVIR Operating marginAVIR Operating cash flowAVIR Free cash flowAVIR Capital expendituresAVIR Return on equityAVIR Stock buybacksAVIR Dividends paidAVIR Total assetsAVIR Total liabilitiesAVIR Shareholders’ equityAVIR overview →